β-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 4, 1997, Pages 436-443

  Nasa, Yoshihisa ^a   Yabe, Ken Ichi ^a   Takeo, Satoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

1 Adrenoceptor; Adrenoceptor; Cardioprotection; Perfused rat heart; Preconditioning

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUNAZOSIN; CREATINE KINASE; ISOPRENALINE; NORADRENALIN; PHENYLEPHRINE; TIMOLOL;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART RATE; HEMODYNAMIC PARAMETERS; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CREATINE KINASE; HEART; HEART RATE; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NOREPINEPHRINE; PHENYLEPHRINE; QUINAZOLINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TIMOLOL; VENTRICULAR FUNCTION, LEFT;

EID: 0030969983     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199704000-00002     Document Type: Article

References (50)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
2. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periodsof ischaemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986;251:H1306-15.
3. Cave AC, Hearse DJ. Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol 1992;24:1113-23.
4. Volovsek A, Subramanian R, Reboussin D. Effects of duration of ischaemia during preconditioning on mechanical function, enzyme release and energy production in the isolated working rat hearts. J Mol Cell Cardiol 1992;24:1011-9.
5. Lasley RD, Anderson GM, Mentzer RM JR. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 1993;27:630-7.
6. Zhai X, Lawson CS, Cave AC, Hearse DJ. Preconditioning and post-ischaemic contractile dysfunction: the role of impaired oxygen delivery vs extracellular metabolite accumulation. J Mol Cell Cardiol 1993;25:847-57.
7. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion induced arrhythmias. Am J Physiol 1987;253: H1470-6.
8. Hagar JM, Hale SL, Kloner RA. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res 1991;68:61-8.
9. Vegh A, Komori S, Szekeres L, Parratt J. Antiarrhythmic effects of preconditioning in anaesthetized dogs and rats. Cardiovasc Res 1992;26:487-95.
10. i proteins. Cardiovasc Res 1993;27:681-7.
11. Asimakis GK, Inners-McBride K, Medellin G, Conti VR. Ischemic preconditioning attenuates acidosis and post-ischemic dysfunction in isolated rat heart. Am J Physiol 1992;263:H887-94.
12. Liu GS, Downey J. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263:H1107-12.
13. Ovize M, Przkklenk K, Hale SL, Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation 1992;85:2247-54.
14. Cave AC. Preconditioning induced protection against post-ischaemic contractile dysfunction: characteristics and mechanisms. J Mol Cell Cardiol 1995;27:969-79.
15. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26:661-8.
16. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-90.
17. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 1995;268:H426-31.
18. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
19. Kitakaze M, Node K, Minamino T, et al. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 1996;93:781-91.
20. 1-adrenergic mechanism. Circ Res 1993;73:656-70.
21. 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 1994;93:2197-205.
22. Schömig A, Dart AM, Dietz R, Mayer E, Kubler W. Release of endogenous catecholamines in the ischemic myocardium of the rat: Part A: locally mediated release. Circ Res 1984;55:689-701.
23. Abrahamsson T, Almgren O, Carlsson L. Ischemia-induced local release of myocardial noradrenaline. J Cardiovasc Pharmacol 1985;7(suppl 5):19-22.
24. Waldenstrom AP, Hjalmarson AC, Thornell L. A possible role of noradrenaline in the development of myocardial infarction: an experimental study in the isolated rat heart. Am Heart J 1978;95:43-51.
25. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291-306.
26. Reimer KA, Rasmussen MM, Jennings RB. Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res 1973;33:353-63.
27. Wexler BC, Kittinger GW. Myocardial necrosis in rats: serum enzymes, adrenal steroid and histopathological alterations. Circ Res 1963;13:159-71.
28. Stanton HC, Brenner G, Mayfield ED Jr. Studies on isoproterenol-induced cardiomegaly in rats. Am Heart J 1969;77:72-80.
29. Martorana PA. The role of cyclic AMP in isoprenaline induced cardiac necrosis in the rat. J Pharm Pharmacol 1971;23:200-3.
30. Vegh A, Szekeres L, Parratt JR. Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res 1991;25:1051-3.
31. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M. Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning. Am J Physiol 1994;266:H2033-41.
32. Talosi L, Kranias EG. Effect of α-adrenergic stimulation on activation of protein kinase C and phosphorylation of proteins in intact rabbit hearts. Circ Res 1992;70:670-8.
33. 1-Adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther 1995;273:689-94.
34. Quantz M, Tchervenkov C, Chiu RCJ. Unique responses of immature hearts to ischemia: functional recovery versus initiation of contracture. J Thorac Cardiovasc Surg 1992;103:927-35.
35. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glibenclamide (Glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther 1993;265:559-64.
36. Bergmeyer HU, Rich W, Butter H, et al. Standardization of methods for estimation of enzyme activity in biological fluids. Z Klin Chem Biochem 1970;8:658-60.
37. Takeo S, Yamada H, Tanonaka K, Hayashi M, Sunagawa N. Possible involvement of membrane-stabilizing action in beneficial effect of beta-adrenoceptor blocking agents on hypoxic and posthypoxic myocardium. J Pharmacol Exp Ther 1990;254:847-56.
38. Hoque ANE, Nasa Y, Abiko Y. Cardioprotective effect of d-propranolol in ischemic-reperfused isolated rat hearts. Eur J Pharmacol 1993;236:269-77.
39. Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol 1977;39:986-93.
40. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res 1990;66:344-54.
41. 31P-NMR study of isolated rat hearts. Am J Physiol 1991;261:H469-78.
42. Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium: dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 1984;55:816-24.
43. Wolfe CL, Sievers RE, Visseren FLJ, Donnelly TJ. Loss of my-ocardial protection after preconditioning correlates with the time course of glycogcn recovery within the preconditioned segment. Circulation 1993;87:881-92.
44. i protein and ATP-sensitive K channel. Heart Vessels 1995;10:294-303.
45. Kolocassides KG, Galinanes M, Hearse DJ. Dichotomy of ischemic preconditioning: improved postischemic contractile function despite intensification of ischemic contracture. Circulation 1996;93:1725-33.
46. Dennis SC, Gevers W, Opie LH. Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol 1991;23:1077-86.
47. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J 1990;4:2881-9.
48. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-85.
49. Suzuki K, Miura T, Miki T, Iimura O. Sympathetic nerves contribute to preconditioning via β-adrenoceptor activation in rabbits [Abstract]. J Mol Cell Cardiol 1995;27:A41.
50. Asimakis GK, Inners-McBride K, Conti VR. Preconditioning with dobutamine in the rat heart [Abstract]. J Mol Cell Cardiol 1995;27:A40.